Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Alzheimer's Disease
Recent news which mentions Alzheimer's Disease
< Previous
1
2
3
Next >
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
September 08, 2024
Tags
Eisai Co Ltd
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
Midsummer News Flashes – Good and Not So Good
August 14, 2024
Tags
coronavirus
tattoo
CRISPR
From
Stock Gumshoe
Alzheimer’s and Parkinson’s Tests and Treatments… plus a Quick COVID-19 (and Long COVID) Update
July 25, 2024
Tags
coronavirus
Doc Gumshoe
Alzheimer's Disease
From
Stock Gumshoe
This Medical Stock Soared Over 80% In Pre-Market After Advancing Gene Therapy Program For ALS, Alzheimer's And Parkinson's Diseases
July 09, 2024
Tickers
ALS
NEWS
WENA
Tags
Benzinga
Stories That Matter
Alzheimer's disease
From
Benzinga
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
July 03, 2024
Tickers
LLY
NEWS
Tags
LLY
Health Care
News
From
Benzinga
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 03, 2024
Tags
Market Outlook
NVIDIA Corp
Medication
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 02, 2024
Tags
Inflation
Tesla Inc
Alzheimer's disease
From
CNBC.com News
EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says
June 21, 2024
Tags
Expert Ideas
Stories That Matter
Alzheimer's disease
From
Benzinga
Op-ed: An Alzheimer’s wave is coming. Here's how to protect your family and your finances
February 09, 2024
Tags
Dementia
Health Care Services
Retirement planning
From
CNBC.com News
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
January 31, 2024
Tickers
BIIB
IONS
NEWS
Tags
Briefs
Stories That Matter
Alzheimer's disease
From
Benzinga
Could CBD Revolutionize Alzheimer's Treatment? New Study Explores Its Neuroprotective Properties
December 04, 2023
Tickers
CBD
Tags
General
Markets
Cannabis
From
Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Tickers
ACIU
BIIB
ESAIY
ESALY
Tags
News
AI Generated
Penny Stocks
From
Benzinga
The MIND diet is touted for its brain-boosting benefits—but can it really lower risk of dementia?: What a neurologist thinks
September 30, 2023
Tags
Make It
Diets and dieting
Health Tips and Wellness Advice
From
CNBC.com News
Autism Therapy: Cannformatics Targets Metabolic Imbalances Using Machine Learning
August 24, 2023
Tickers
TECH
Tags
Nature's Scientific Reports
PTSD cannabis
Autism
From
Benzinga
Bill Gates used to think this habit was lazy and 'unnecessary'—now it's his No. 1 key for a healthy brain
August 03, 2023
Tags
Make It / Power Players
Make It / Success
Science
From
CNBC.com News
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
August 02, 2023
Tickers
POTX
TOKE
Tags
News
Health Care
TOKE
From
Benzinga
Medicare Part B premiums may increase in 2024, prompted by a new Alzheimer's treatment
July 20, 2023
Tags
Social issues
Alzheimer's disease
Social Security
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
Biotechnology
Biogen Inc
US: News
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
Biotech and Pharmaceuticals
Politics
U/S/ Economy
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
Health care industry
Eisai Co Ltd
Regulations
From
CNBC.com News
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
July 07, 2023
Tickers
ALZN
BIIB
LLY
SAVA
Tags
Top Stories
Penny Stocks
LLY
From
Benzinga
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
July 06, 2023
Tags
Health & Science
Breaking News: Business
Business News
From
CNBC.com News
Alzheimer’s Disease, RSV, Migraines and more…
June 22, 2023
Tags
Teva Pharmaceuticals (TEVA)
Abbvie (ABBV)
Migraine
From
Stock Gumshoe
Exclusive: FloraWorks Completes $2.25M Series-A Financing For Cannabinoid Research
June 21, 2023
Tags
sleep disorders
Exclusives
News
From
Benzinga
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
June 07, 2023
Tags
Politics
Biotech and Pharmaceuticals
Policy
From
CNBC.com News
Medicare details plan to cover Alzheimer's treatments
June 01, 2023
Tags
U/S/ Economy
Health care industry
Policy
From
CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
Tags
Politics
Biotech and Pharmaceuticals
Policy
From
CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
May 03, 2023
Tags
Biotech and Pharmaceuticals
US Top News and Analysis
Politics
From
CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
May 03, 2023
Tags
Alzheimer's disease
Science
Business
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Biogen Inc
Biotechnology
US: News
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.